Outlook Therapeutics, Inc.

NasdaqCM:OTLK Stock Report

Market Cap: US$34.8m

Outlook Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:OTLK Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
26 Sep 24BuyUS$28,446Lawrence KenyonIndividual5,000US$5.69
28 Mar 24BuyUS$22,242Yezan HaddadinIndividual1,881.71US$11.82
07 Mar 24BuyUS$26,243Jeffrey EvansonIndividual3,124.2US$8.40
30 Jan 24SellUS$1,384,379GMS Tenshi Holdings Pte. LimitedCompany135,723.45US$10.20

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of OTLK?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders76,8050.325%
Private Companies2,537,28910.7%
General Public6,924,62529.3%
Institutions7,015,81529.7%
VC/PE Firms7,101,10230%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 81.8%.

Top Shareholders

Top 25 shareholders own 69.73% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
24.6%
GMS Ventures & Investments
5,808,074US$8.5m0%no data
7.21%
Syntone Technologies Group Co. Ltd.
1,705,438US$2.5m0%no data
6.59%
Tang Capital Management, LLC
1,559,560US$2.3m-3.7%0.17%
5.47%
Great Point Partners, LLC
1,293,028US$1.9m-24%0.73%
4.42%
BlackRock, Inc.
1,044,988US$1.5m57.5%no data
3.62%
The Vanguard Group, Inc.
855,876US$1.3m56.3%no data
3.52%
GMS Tenshi Holdings Pte. Limited
831,851US$1.2m0%no data
2.29%
Altium Capital Management LP
541,549US$796.1k7.92%0.25%
1.9%
Rosalind Advisors, Inc.
450,000US$661.5k0%0.4%
1.75%
Sphera Funds Management Ltd
413,545US$607.9k-27.6%0.1%
1.45%
Geode Capital Management, LLC
341,959US$502.7k49.2%no data
1.35%
Caligan Partners, LP
318,699US$468.5k-36.3%0.15%
1.21%
Schonfeld Strategic Advisors LLC
285,714US$420.0k0%no data
0.98%
State Street Global Advisors, Inc.
232,542US$341.8k10%no data
0.67%
Boothbay Fund Management, LLC
159,350US$234.2k-36.3%0.01%
0.64%
Woodline Partners LP
151,508US$222.7k0.48%no data
0.5%
Northern Trust Global Investments
118,869US$174.7k42.5%no data
0.39%
Federated Hermes, Inc.
91,419US$134.4k0%no data
0.22%
Charles Schwab Investment Management, Inc.
51,459US$75.6k55.1%no data
0.2%
LVW Advisors, LLC
47,730US$70.2k0%0.01%
0.18%
Morgan Stanley, Investment Banking and Brokerage Investments
41,431US$60.9k343%no data
0.17%
Susquehanna Fundamental Investments, LLC
41,020US$60.3k0%no data
0.16%
XTX Holdings Limited, Asset Management Arm
37,328US$54.9k0%no data
0.16%
Jeffrey Evanson
37,298US$54.8k0%no data
0.15%
Goldman Sachs Group, Investment Banking and Securities Investments
35,574US$52.3k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 08:35
End of Day Share Price 2024/12/24 00:00
Earnings2024/06/30
Annual Earnings2023/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Outlook Therapeutics, Inc. is covered by 12 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward WooAscendiant Capital Markets LLC
Brian Kemp DolliverBrookline Capital Markets
Kumaraguru RajaBrookline Capital Markets